A Bright Outlook for Gene Editing Investing

With biotechnology stocks heavily out of favor at the moment, it's not surprising that some investors are ignoring genomics assets.

Related Keywords

Ali Urman ,Sector Fund ,Revolution Multi Sector Fund ,Zinc Finger ,Etf ,Tfs ,Xchange Traded Funds ,Money ,Stock Market ,Ark Investment Management ,Markg ,Isruptive Technology Channel , ,